Diagnostic Imaging Europe
November 2005
COVER STORY
News
Report: Neuroradiology
Report: Gastrointestinal
Report: Pediatric Radiology
DEPARTMENTS
From The Editor
The Big Picture
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.